LV
corporate_vc

Lilly Asia Ventures

Lilly Asia Ventures is a corporate venture arm based in China, investing in Healthcare & Life Sciences; Consumer, Lifestyle & Services and Energy, Environment & Mobility, 28 tracked investments.

28
Investments Tracked

About Lilly Asia Ventures

Lilly Asia Ventures is a corporate venture arm headquartered in China. We have recorded 28 investments for Lilly Asia Ventures to date.

Sector activity concentrates in Healthcare & Life Sciences; Consumer, Lifestyle & Services; Energy, Environment & Mobility and Oncology. Coverage extends to 8 sectors in total. Participation spans Series A, Series B and Series C+ rounds.

Focuses on early and growth-stage investments in the healthcare and life sciences sectors across Asia. They target companies with innovative technologies and strong growth potential.

Investment Focus

Stage Focus
series-aseries-bseries-c-plus
Sectors
Healthcare & Life SciencesConsumer, Lifestyle & ServicesEnergy, Environment & MobilityOncologyPersonalized Medicinepharmaceutical-developmentbiotechnologypharmaceuticals

Investment Thesis

Focuses on early and growth-stage investments in the healthcare and life sciences sectors across Asia. They target companies with innovative technologies and strong growth potential.

Lilly Asia Ventures Portfolio Companies

24 of 28 tracked holdings.

Lynk PharmaceuticalsChina
CARsgen TherapeuticsChina
Sciwind BiosciencesChina
Insilico MedicineUnited States
dMedChina
Qihan BiotechChina
Regor TherapeutiscChina
Scivita Medical TechnologyHong Kong
ArriVentUnited StatesKSQ TherapeuticsUnited StatesNucleixUnited StatesPulnovoIsrael
Starna TherapeuticsChina
Centrexion TherapeuticsUnited StatesSynthekineUnited StatesNewMedChina
Virtue DiagnosticsSingapore
Cornerstone AdvisorsAllTimberlyneUnited StatesTriastekChinaVerdiva BioGermanyComanche BiopharmaAllPrecede BiosciencesUnited StatesLyell ImmunopharmaUnited States
Portfolio outcomes
13 active1 acquired6.7% exit rate

Explore Lilly Asia Ventures's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in China

Other Investors in Healthcare & Life Sciences / Consumer, Lifestyle & Services